{
    "Trade/Device Name(s)": [
        "HardyCHROM ESBL",
        "HardyCHROM\u2122 ESBL",
        "HardyCHROMTM ESBL agar"
    ],
    "Submitter Information": "Hardy Diagnostics",
    "510(k) Number": "K160512",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122187"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JSO"
    ],
    "Summary Letter Date": "October 4, 2016",
    "Summary Letter Received Date": "October 11, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1700"
    ],
    "Regulation Name(s)": [
        "Culture medium for antimicrobial susceptibility tests"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Enterobacteriaceae potentially non-susceptible to ceftazidime",
        "Enterobacteriaceae potentially non-susceptible to cefpodoxime",
        "Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli",
        "Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae",
        "Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella oxytoca"
    ],
    "Specimen Type(s)": [
        "Stool",
        "Fecal specimen"
    ],
    "Specimen Container(s)": [
        "C&S Medium (modified Cary Blair formula)",
        "Raw specimen container"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Selective chromogenic medium",
        "Enzymatic",
        "Chromogenic"
    ],
    "Methodologies": [
        "Selective and differential culture"
    ],
    "Submission Type(s)": [
        "Culture medium"
    ],
    "Document Summary": "FDA 510(k) summary for HardyCHROM ESBL, a selective chromogenic medium for presumptive detection of ESBL-producing and cephalosporin non-susceptible Enterobacteriaceae from stool specimens",
    "Indications for Use Summary": "Selective and differential chromogenic medium for qualitative, presumptive detection from stool specimens of Enterobacteriaceae potentially non-susceptible to ceftazidime and cefpodoxime, and ESBL-producing E. coli, K. pneumoniae, and K. oxytoca; aids detection, identification of colonization, and control of these bacteria in healthcare settings, not for infection diagnosis or treatment guidance",
    "fda_folder": "Microbiology"
}